Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name 'Valiant Laboratories Limited' through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.
The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide ...and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.
Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.
Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL).
In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.
The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.
1. Can I buy Valiant Laboratories Ltd from PL Capital? ›
Yes, you can invest in Valiant Laboratories Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Valiant Laboratories Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Valiant Laboratories Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Valiant Laboratories Ltd pay dividends? ›
Valiant Laboratories Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Valiant Laboratories Ltd ? ›
As of
05-12-2025 the share price for Valiant Laboratories Ltd. is 71.63 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Valiant Laboratories Ltd ? ›
The 52-week high and low of Valiant Laboratories Ltd share price is ₹ 63.86 - ₹ 120.92 as of
05-12-2025 .
PL Ringside View
Our fireside chat series where industry experts and top management share valuable insights for our clients
